Trial Profile
The Influence of BCG Vaccine as a Booster TDaP-IPV Vaccination: an Explorative Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs BCG vaccine (Primary) ; DTaP poliovirus vaccine (Primary)
- Indications Pertussis
- Focus Pharmacodynamics
- 12 Oct 2016 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 17 May 2016 New trial record